B. Gerstmayer et al., COSTIMULATION OF T-CELL PROLIFERATION BY A CHIMERIC B7-ANTIBODY FUSION PROTEIN, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 156-158
T cells require at least two signals for activation and clonal expansi
on. The first signal conferring specificity is initiated by interactio
n of the T cell receptor with peptide-bearing MHC molecules. The secon
d, costimulatory signal can be provided by cell-surface molecules on a
ntigen-presenting cells such as B7-1 (CD80) and B7-2 (CD86), which int
eract with CD28 on T cells. To direct the costimulatory B7-2 molecule
to the surface of tumor cells we have constructed a chimeric fusion pr
otein, which consists of the extracellular domain of human B7-2 fused
to a single-chain antibody domain (scFv) specific for the ErbB2 protei
n, a type I growth factor receptor overexpressed in a high percentage
of human adenocarcinomas. This B7-2(225)-scFv(FRP5) molecule, expresse
d in the yeast Pichia pastoris and purified from culture supernatants,
binds to B7 counter-receptors and to ErbB2. B7-2(225)scFv(FRP5) local
izes specifically to the surface of ErbB2-expressing target cells, the
reby providing a costimulatory signal, which results in enhanced proli
feration of syngeneic T cells.